Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ADVB
Advanced Biomed Inc. Common Stock
Healthcare | Medical - Diagnostics & Research
$4.51+0.11 (+2.50%)as of 2026-07-15 02:25 UTC
Volume13.1K
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB) is a medical - diagnostics & research company trading at $4.51 (+2.5% today). Figures from SEC EDGAR and market feeds; updated 2026-07-15 02:25 UTC.
52-Week Range
Low $3.61High $19.60
What Advanced Biomed Inc. Common Stock does
Advanced Biomed is a Nevada-incorporated holding company that operates through subsidiaries in Taiwan and Hong Kong to develop microfluidic technology platforms for cancer detection and treatment. The company integrates semiconductor and biotechnology to create medical testing devices and biochips that detect circulating tumor cells and tumor markers in blood samples for early screening, diagnosis, and treatment assistance. Its product portfolio includes devices such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, along with matching immunostaining kits and an early lung cancer screening kit.
Summarized from Advanced Biomed Inc. Common Stock’s SEC filings · Read the filing ↗
Advanced Biomed is a Nevada-incorporated holding company that operates through subsidiaries in Taiwan and Hong Kong to develop microfluidic technology platforms for cancer detection and treatment.
What is ADVB's valuation?
ADVB trades at $4.51, as of 2026-07-15.
When did ADVB last file with the SEC?
Advanced Biomed Inc. Common Stock's most recent SEC filing on record is a 8-K filed 2026-07-01. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-15 02:25 UTC. This page is also available as JSON at /api/data?ticker=ADVB and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ADVB and 3,500+ tickers.
